Clinical Trials Browser

Phase 2 × Tongue Neoplasms × Bortezomib × Clear all

NCT00103259 2014-05-23

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

71 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms